Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vaccine Maker Merck Says There Is No Published Scientific Evidence That Shows Any Benefit In Separating The Combination MMR Vaccine Into Three Individual Shots; There Are No Approved U.S. Monovalent Measles, Mumps And Rubella Single Antigen Vaccines

Author: Benzinga Newsdesk | October 06, 2025 01:58pm

-Reuters

Posted In: MRK